RTI Surgical received FDA 510(k) clearance to market the Dynamic Active Compression (DAC) Plate for stabilization and fixation of small foot bones. This represents the company's first 510(k) clearance since RTI became an independent orthopedic contract manufacturer with its purchase by Montagu Private Equity.
DAC combines the rigid stability of a plate with nitinol's ability to provide continuous compression and ensure apposition of bony surfaces during healing.
"The DAC plate is a prime example of how we are able to leverage our core capabilities to enter a new market. Our trauma experience was crucial in creating the first hardware product we specifically designed for lower extremities in the foot and ankle space. We look forward to continuing to bring new technologies to the market to address unmet needs and help patients," said Jimmy Blanchard, Vice President of Sales.
As a surgical implant supplier, RTI partners with medical technology companies to design and develop medical devices. RTI also designs, develops and manufactures novel technologies which are commercialized through multiple distribution channels.